APA (7th ed.) Citation
(2026). Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study. Medical Mycology.
Chicago Style (17th ed.) Citation
"Lipid-based Amphotericin B Formulations (ABCD/L-AmB) Were Associated with Better Outcomes than Deoxycholate (AmB-d) in Non-HIV-associated Cryptococcal Meningitis: A Retrospective Cohort Study." Medical Mycology 2026.
MLA (9th ed.) Citation
"Lipid-based Amphotericin B Formulations (ABCD/L-AmB) Were Associated with Better Outcomes than Deoxycholate (AmB-d) in Non-HIV-associated Cryptococcal Meningitis: A Retrospective Cohort Study." Medical Mycology, 2026.
Warning: These citations may not always be 100% accurate.